EUVIMEDEUVIMED entdecken
Klinische Studie

Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS‐331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika

Leandro Schiavo Vilhena iD, Aline Campos de Azevedo da Silva, Diego Medeiros Dias da Silva, Douglas Pereira Pinto iD, Estephane Fernandes Coelho, João Felipe Garcia Medeiros de Araújo, Gabriel Parreiras Estolano da Silveira, Heliana Martins Pereira, Letícia de Sá Fernandes Vallim da Silva, Rita de Cássia Elias Estrela Marins, Roberta Ghilosso Bortolini, Thiago Moreno L Souza und 4 weitere

Biomedical Chromatography · 2023

DOI: 10.1002/bmc.5606 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Leandro Schiavo Vilhena und 15 weiteren Autor:innen. Beteiligte Einrichtung: Equivalence and Pharmacokinetics Laboratory (SEFAR), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: Zika Virus, Zika Virus Infection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Oswaldo Cruz Foundation (Fiocruz), Blanver Farmoquímica Ltda, Microbiológica Química e Farmacêutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zika still poses a threat to global health owing to its association with serious neurological conditions and the absence of a vaccine and treatment. Sofosbuvir, an anti‐hepatitis C drug, has shown anti‐Zika effects in animal and cell models. Thus, this study aimed to develop and validate novel LC–MS/MS methods for the quantification of sofosbuvir and its major metabolite (GS‐331007) in human plasma and cerebrospinal (CSF) and seminal fluid (SF), and apply the methods to a pilot clinical trial. The samples were prepared by liquid–liquid extraction and separated using isocratic mode on Gemini C 18 columns. Analytical detection was performed using a triple quadrupole mass spectrometer equipped with an electrospray ionization source. The validated ranges for sofosbuvir were 0.5–2,000 ng/mL (plasma) and 0.5–100 ng/mL (CSF and SF), while for the metabolite they were 2.0–2,000 ng/mL (plasma), 5.0–200 ng/mL (CSF) and 10–1,500 ng/mL (SF). The intra‐day and inter‐day accuracies (90.8–113.8%) and precisions (1.4–14.8%) were within the acceptance range. The developed methods fulfilled all validation parameters concerning selectivity, matrix effect, carryover, linearity, dilution integrity, precision, accuracy and stability, confirming the suitability of the method for the analysis of clinical samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusZika Virus InfectionAnimalsHumansChromatography, LiquidLimit of DetectionPlasmaReproducibility of ResultsSofosbuvirTandem Mass Spectrometry

Stichwörter der Autor:innen

GS-331007LC-MS/MSZikahuman matricessofosbuvir

Substanzen

Sofosbuvir

Autor:innen und Institutionen

  • Equivalence and Pharmacokinetics Laboratory (SEFAR), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
  • National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Cidade Universitária da Universidade Federal do Rio de Janeiro, CEP 21941-580, Rio de Janeiro, RJ, Brazil.
  • Center for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Pharmacology Laboratory, Department of Pharmacodynamics and Physiology, National Institute for Quality Assurance in Health, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.

ORCID-Profile: Leandro Schiavo Vilhena, Douglas Pereira Pinto

Förderung

  • Oswaldo Cruz Foundation (Fiocruz)
  • Blanver Farmoquímica Ltda
  • Microbiológica Química e Farmacêutica
  • Karin Bruning
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)-finance
  • Fundação Oswaldo Cruz

Zitieren

APA

Vilhena, L. S., de Azevedo da Silva, A. C., Dias da Silva, D. M., Pinto, D. P., Coelho, E. F., de Araújo, J. F. G. M., da Silveira, G. P. E., Pereira, H. M., da Silva, L. S. F. V., Estrela Marins, R. C. E., Bortolini, R. G., Souza, T. M. L., Dos Santos, V. G. V., de Assis Nascimento, V., Amendoeira, F. C., & da Fonseca, L. B. (2023). Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS‐331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika. Biomedical Chromatography. https://doi.org/10.1002/bmc.5606

Vancouver

Vilhena LS, de Azevedo da Silva AC, Dias da Silva DM, Pinto DP, Coelho EF, de Araújo JFGM, et al. Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS‐331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika. Biomedical Chromatography. 2023. doi:10.1002/bmc.5606

BibTeX
@article{Vilhena2023,
  author = {Vilhena, Leandro Schiavo and de Azevedo da Silva, Aline Campos and Dias da Silva, Diego Medeiros and Pinto, Douglas Pereira and Coelho, Estephane Fernandes and de Araújo, João Felipe Garcia Medeiros and da Silveira, Gabriel Parreiras Estolano and Pereira, Heliana Martins and da Silva, Letícia de Sá Fernandes Vallim and Estrela Marins, Rita de Cássia Elias and Bortolini, Roberta Ghilosso and Souza, Thiago Moreno L and Dos Santos, Valdiléa Gonçalves Veloso and de Assis Nascimento, Viviane and Amendoeira, Fábio Coelho and da Fonseca, Laís Bastos},
  title = {Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS‐331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika},
  journal = {Biomedical Chromatography},
  year = {2023},
  doi = {10.1002/bmc.5606}
}
Kostenlos starten →